Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | NAB2 |
| Upstream (Parents) |
|---|
| (<<) ATP2A2 → NAB2 |
| (<<) BCL3 → NAB2 |
| (<<) EGR1 → NAB2 |
| (<<) FZD2 → NAB2 |
| (<<) GALR3 → NAB2 |
| (<<) HMGCS1 → NAB2 |
| (<<) ITGA2 → NAB2 |
| (<<) LDLR → NAB2 |
| (<<) LIPG → NAB2 |
| (<<) NFAT5 → NAB2 |
| (<<) PTAFR → NAB2 |
| (<<) SOX18 → NAB2 |
| (<<) TPM3 → NAB2 |
| Downstream (Children) |
|---|
| NAB2 → MAP2K2 (>>) |
| NAB2 → MYL3 (>>) |
| NAB2 → PAK2 (>>) |
| NAB2 → SHC1 (>>) |
| NAB2 → WNT4 (>>) |
